Feasibility and Efficacy of a Digital Mental Health Intervention for Teen Wildfire Survivors

November 23, 2020 updated by: Adrienne Julie Heinz, Stanford University

Feasibility and Preliminary Efficacy of a Digital Mental Health Intervention to Reduce Symptoms of Post-Disaster Traumatic Stress, Depression, and Anxiety in Teens Impacted by Wildfires: A Randomized Multiple-Baseline Single-Case Study.

In October, 2017, Northern California experienced devastating and historic wildfires. Sonoma Rises is an app designed for anyone who was impacted by this event and is intended to help survivors of disaster find their new normal. This study will assess the feasibility and efficacy of a self-help post-disaster mental health intervention delivered via a mobile app with a sample of teens who are experiencing post-disaster mental health symptoms.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Palo Alto, California, United States, 94304
        • Stanford University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 17 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Males & females aged 13-17 years directly impacted by the 2017 wildfires having lost their home or been temporarily displaced
  2. Screen positive for PTSD (Child Trauma Screening Questionnaire = 5 or higher)
  3. Have regular access to a smart phone and a computer
  4. Have a personal email address
  5. Speak and read English fluently
  6. Have parental consent

Exclusion Criteria:

  1. A positive self-reported history of psychosis, bipolar, or schizophrenia
  2. Serious self-reported physical health concerns necessitating surgery or with prognosis <6 months
  3. A positive screen for a current Substance User Disorder (CRAFFT = 2 or higher)
  4. Current self-reported suicidal ideation
  5. Self-reported pregnancy
  6. Self-reported less than four weeks of stable prescription medication for anxiety, anti-depressant, and sleep promoting medications prior to the screening assessment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Single Arm
21 male and female teenage participants will be randomized to one of three varying baseline assessment periods of two, four, or six weeks. Multiple baseline is a type of single-case experimental design (SCED) that is a time- and cost-effective method for evaluating efficacy of a new treatment, Sonoma Rises. The randomization of participants to baseline periods of varying lengths enables assessment of whether symptom changes occur when, and only when, the intervention is applied.
All participants will receive the intervention, Sonoma Rises, a mobile app designed by psychologists at the National Center for PTSD for wildfire survivors to facilitate recovery from disaster. Users can access evidence-informed tools to help cope with stress, heal from loss, prioritize self-care, connect with others, manage anger, and track their mood using validated assessments. There are also tools designed just for teens and users are linked to psychoeducation on disaster and health and other mental health resources and services.
Other Names:
  • Mobile Mental Health App

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility: intervention retention: number of treatment completers
Time Frame: 4 months
retention (i.e., number of treatment completers)
4 months
Feasibility: intervention safety: number of adverse events
Time Frame: 4 months
safety (i.e., number of adverse events)
4 months
Feasibility: intervention adherence: number of treatment components completed
Time Frame: 4 months
adherence rates (i.e., number of treatment components completed)
4 months
Feasibility: intervention satisfaction/acceptability
Time Frame: 4 months
satisfaction/acceptability (i.e., participant satisfaction with treatment "how would you rate your overall satisfaction with the program?"- range 0-10 - higher score indicates more satisfaction)
4 months
Feasibility: intervention promotion
Time Frame: 4 months
Net promoter score (i.e., "How likely are you to recommend this to a friend?" score range 0-5; lower score indicates higher likelihood of promotion)
4 months
Feasibility: engagement rate
Time Frame: 4 months
Engagement rate (i.e., Number and average length of logins to the mobile app intervention)
4 months
PTSD Symptom Severity
Time Frame: 4 months
Child PTSD Symptom Scale for Diagnostic and Statistical Manual-5; score ranges from 0-80; higher scores indicate more PTSD symptom severity
4 months
PTSD functional impairment
Time Frame: 4 months
Child PTSD Symptom Scale for Diagnostic and Statistical Manual-5; score ranges from 0-7; higher scores indicate more PTSD related functional impairment
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Internalizing symptoms
Time Frame: 4 months
Behavior and Feelings Survey - Youth; range 0-24; higher scores indicate more internalizing symptoms (anxiety, depression, stress)
4 months
Externalizing symptoms
Time Frame: 4 months
Behavior and Feelings Survey- Youth; range 0-24; higher scores indicate more externalizing symptoms (behavior problems)
4 months
Psychosocial functioning
Time Frame: 4 months
Ohio Youth Scale - Functioning Subscale; Score range 0-80; higher score indicated better functioning
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adrienne Heinz, Ph.D., Stanford University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2019

Primary Completion (Actual)

January 31, 2020

Study Completion (Actual)

November 22, 2020

Study Registration Dates

First Submitted

March 5, 2019

First Submitted That Met QC Criteria

March 8, 2019

First Posted (Actual)

March 11, 2019

Study Record Updates

Last Update Posted (Actual)

November 24, 2020

Last Update Submitted That Met QC Criteria

November 23, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB-49196

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PTSD

Clinical Trials on Sonoma Rises

Subscribe